发明名称 |
Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment |
摘要 |
The present invention provides methods for determining if a patient is likely to benefit from a cancer treatment, by determining if said patient has a gut dysbiosis with an over representation of certain bacterial species. The present invention also provides probiotic strains to improve the efficacy of a cancer treatment, especially chemotherapy, in patients in need thereof. |
申请公布号 |
AU2014351348(A1) |
申请公布日期 |
2016.06.09 |
申请号 |
AU20140351348 |
申请日期 |
2014.11.21 |
申请人 |
INSTITUT GUSTAVE ROUSSY |
发明人 |
ZITVOGEL, LAURENCE;GOMPERTS BONECA, IVO;LEPAGE, PATRICIA;VIAUD, SOPHIE;DAILLERE, ROMAIN |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|